CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Planning for Phase 3 Registration Trial of CAD-1005 in HIT On April ...

Heart problems can increase dementia risk, but a new study suggests that heparin, a common anticoagulant administered via injection, may help delay Alzheimer’s onset. Image credit: wang mengmeng/Getty ...

New research reveals that patients receiving heparin therapy were diagnosed with Alzheimer's disease up to two years later, suggesting a possible protective effect of this common anticoagulant. Study: ...

Heparin treatment was associated with a delayed diagnosis of Alzheimer's dementia, electronic health records in two U.S. health systems showed. (Molecular Psychiatry) Analyses of cell types after ...

Taurolidine is an antibacterial and antifungal agent with a mechanism of action that is less prone to development of antimicrobial resistance. A taurolidine/heparin lock solution carries a lower risk ...

Francisco Miras-Parra; Emilia Navascués-Martínez; Antonio Gómez-Outes; Javier Martínez-González; Eduardo Rocha; on behalf of the Bemiparin Cooperative Study Group in Medical Patients Introduction: ...

Researchers at the Spanish National Research Council (CSIC) Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) have discovered and synthesized a number of molecules that inhibit the effects of ...

For decades, the blood thinner heparin has been used to prevent and treat blood clots. Could it be just as effective in treating cancer? In an editorial published Feb. 15 in the New England Journal of ...

Phase II study of the insulin-like growth factor-1 receptor (IGF-1R) antibody cixutumumab (C) in patients (pts) with thymoma (T) and thymic carcinoma (TC). Background: Approximately one third of ...